Suppr超能文献

SIRT1 通过上调 DNA 聚合酶 δ1(POLD1)促进乳腺癌细胞 MCF-7 的增殖、迁移和侵袭。

SIRT1 promotes proliferation, migration, and invasion of breast cancer cell line MCF-7 by upregulating DNA polymerase delta1 (POLD1).

机构信息

Department of Breast Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.

出版信息

Biochem Biophys Res Commun. 2018 Jul 20;502(3):351-357. doi: 10.1016/j.bbrc.2018.05.164. Epub 2018 May 30.

Abstract

Sirtuin 1 (SIRT1), class III histone deacetylase, plays an important character in cell proliferation, cell cycle, apoptosis, energy metabolism and DNA repair. In recent years, researchers have attached increasing attention on the role of SIRT1 in tumorigenesis, development and drug resistance. The effect of SIRT1 on breast cancer is still controversial and its exact role remains to be elucidated. In the present study, we investigated the significant role of SIRT1 in breast cancer by exploring the effect of SIRT1 on DNA polymerase delta1 (POLD1), the gene coding for DNA polymerase δ catalytic subunit p125. Immunohistochemistry showed that the protein expression level of SIRT1 was higher in breast cancer tissues relative to adjacent normal tissues. Knockdown of SIRT1 by shRNA decreased the proliferation, migration, and invasion of human breast cancer cell line MCF-7, while the overexpression of SIRT1 promoted the proliferation, migration, and invasion of MCF-7 cells. Clinically, the immunohistochemistry results revealed that the expression of SIRT1 was positively correlated with p125. Further analysis demonstrated that silencing of SIRT1 increased the expression of p53, while the expression level of POLD1/p125 decreased, and the result by overexpressing SIRT1 was opposite. Collectively, these data suggest that SIRT1 is an oncogenic factor in breast cancer cells and can be involved in the progression of breast cancer by inhibiting p53 and activating POLD1. Our finding provides new insights into the mechanisms of breast cancer.

摘要

Sirtuin 1(SIRT1)是 III 类组蛋白去乙酰化酶,在细胞增殖、细胞周期、细胞凋亡、能量代谢和 DNA 修复中发挥重要作用。近年来,研究人员越来越关注 SIRT1 在肿瘤发生、发展和耐药性中的作用。SIRT1 对乳腺癌的影响仍存在争议,其确切作用仍有待阐明。在本研究中,我们通过研究 SIRT1 对 DNA 聚合酶 delta1(POLD1)的影响,探讨了 SIRT1 在乳腺癌中的重要作用,POLD1 基因编码 DNA 聚合酶 δ 的催化亚基 p125。免疫组化结果显示,SIRT1 蛋白在乳腺癌组织中的表达水平高于相邻正常组织。shRNA 敲低 SIRT1 可降低人乳腺癌 MCF-7 细胞系的增殖、迁移和侵袭能力,而过表达 SIRT1 则促进 MCF-7 细胞的增殖、迁移和侵袭。临床方面,免疫组化结果表明 SIRT1 的表达与 p125 呈正相关。进一步分析表明,沉默 SIRT1 可增加 p53 的表达,而 POLD1/p125 的表达水平降低,而过表达 SIRT1 的结果则相反。综上所述,这些数据表明 SIRT1 是乳腺癌细胞中的致癌因子,可通过抑制 p53 和激活 POLD1 参与乳腺癌的进展。我们的研究结果为乳腺癌的发生机制提供了新的见解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验